Malaria’s impact on growth continues to be a critical concern for healthcare systems and emerging economies, particularly in regions where the disease remains endemic. The reality of slow progress becomes evident when evaluating how malaria...
In a move to strengthen workforce readiness, the Pharmaceutical Academy for Global Excellence (PAGE) has partnered with 8chili Inc. to roll out an AI and VR pharma manufacturing training platform in India. The initiative targets a critical skills...
A counterfeit medicine operation involving fake versions of Mounjaro has come under investigation in India after packaging errors exposed suspicious products circulating in the market. Authorities say the discovery highlights growing concern...
Gujarat Themis Biosyn Limited (GTBL) has announced a major step in its global expansion with the signing of an agreement to acquire a portfolio of anti-tuberculosis and anti-infective brands from Sanofi. The GTBL acquisition of Sanofi TB...
The Merck & Google Cloud partnership is set to reshape how one of the world’s largest pharmaceutical companies operates, with a deal worth up to USD 1 billion aimed at turning Merck into a fully AI-enabled enterprise.
Biocon denosumab biosimilars have secured a major regulatory win, with Health Canada granting a Notice of Compliance (NOC) for two of the company’s products—Bosaya and Vevzuo—on April 3, 2026. The approval marks a significant step as Biocon...
Scientists have uncovered a new clue about how anxiety disorders may develop in the brain, pointing to a surprising source — the brain’s own immune cells in the brain. A recent study conducted in mice suggests that calcium activity inside speciali...
Indian drugmaker Cipla has received approval from the USFDA approval process for a generic respiratory inhaler used to treat breathing-related conditions. The approval strengthens the company’s growing presence in the U.S. pharmaceutical mark...
Novo Nordisk reported positive Phase 3 results today for its semaglutide pill, marking a key step toward expanding diabetes treatment for younger patients. The late-stage trial, known as PIONEER TEENS, tested the oral drug in children aged...
Shares of Alembic Pharmaceuticals edged up 1.09 percent to Rs 772.55 after the company revealed plans to strengthen its global footprint with a new subsidiary in Southeast Asia. The move signals Alembic Pharmaceuticals’ continued push into...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")